| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |